|
1）Jones PA, Baylin SB. A decade of exploring the cancer epigenome-biological and translational implications. Nat Rev Cancer. 2011; 11: 726-34
|
|
|
|
2）Rodriguez-Paredes M, Esteller M. Cancer epigenetics reaches mainstream oncology. Nat Med. 2011; 17: 330-9
|
|
|
|
|
|
3）Dawson MA, Kouzarides T. Cancer epigenetics: from mechanism to therapy. Cell. 2012; 150: 12-27
|
|
|
|
|
4）You JS, Jones PA. Cancer genetics and epigenetics: two sides of the same coin? Cancer Cell. 2012; 22: 9-20
|
|
|
|
|
|
5）Cimmino L, Abdel-Wahab O, Levine RL, et al. TET family proteins and their role in stem cell differentiation and transformation. Cell Stem Cell. 2011; 9: 193-204
|
|
|
|
|
|
6）Trowbridge JJ, Snow JW, Kim J, et al. DNA methyltransferase 1 is essential for and uniquely regulates hematopoietic stem and progenitor cells. Cell Stem Cell. 2009; 5: 442-9
|
|
|
|
|
|
7）Broske AM, Vockentanz L, Kharazi S, et al. DNA methylation protects hematopoietic stem cell multipotency from myeloerythroid restriction. Nat Genet. 2009; 41: 1207-15
|
|
|
|
|
|
8）Hong J, Ehrlich LIR, Seita J, et al. Compre-hensive methylome map of lineage commitment from haematopoietic progenitors. Nature. 2010; 467: 338-43
|
|
|
|
|
|
9）Tadokoro Y, Ema H, Okano M, et al. De novo DNA methyltransferase is essential for self-renewal, but not for differentiation, in hemato-poietic stem cells. J Exp Med. 2007; 204: 715-22
|
|
|
|
|
|
10）Challen GA, Sun D, Jeong M, et al. Dnmt3a is essential for hematopoietic stem cell differ-entiation. Nat Genet. 2011; 44: 23-31
|
|
|
|
|
|
11）Moran-Crusio K, Reavie L, Shih A, et al. Tet2 loss leads to increased hematopoietic stem cell self-renewal and myeloid transformation. Cancer Cell. 2011; 20: 11-24
|
|
|
|
|
|
12）Quivoron C, Couronne L, Della Valle V, et al. TET2 inactivation results in pleiotropic hematopoietic abnormalities in mouse and is a recurrent event during human lymphomagenesis. Cancer Cell. 2011; 20: 25-38
|
|
|
|
|
|
13）Bernstein BE, Mikkelsen TS, Xie X, et al. A bivalent chromatin structure marks key deve-lopmental genes in embryonic stem cells. Cell. 2006; 125: 315-26
|
|
|
|
|
|
14）Sauvageau M, Sauvageau G. Polycomb group proteins: multi-faceted regulators of somatic stem cells and cancer. Cell Stem Cell. 2010; 7: 299-313
|
|
|
|
|
|
15）Konuma T, Oguro H, Iwama A. Role of polycomb group proteins in hematopoietic stem cells. Dev Growth Differ. 2010; 52: 505-16
|
|
|
|
|
16）Oguro H, Yuan J, Ichikawa H, et al. Poised lineage specification in multipotential hemato-poietic stem and progenitor cells by the polycomb protein Bmi1. Cell Stem Cell. 2010; 5: 279-86
|
|
|
|
|
|
17）Oguro H, Iwama A, Morita Y, et al. Differential impact of Ink4a and Arf on hematopoietic stem cells and their bone marrow microenvironment in Bmi1-deficient mice. J Exp Med. 2006; 203: 2247-53
|
|
|
|
|
|
18）Oguro H, Yuan J, Tanaka S, et al. Lethal myelofibrosis induced by Bmi1-deficient hematopoietic cells unveils a tumor suppressor function of the polycomb group genes. J Exp Med. 2012; 209: 445-54
|
|
|
|
|
|
19）Ernst T, Chase AJ, Score J, et al. Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders. Nat Genet. 2010; 42: 722-6
|
|
|
|
|
|
20）Score J, Hidalgo-Curtis C, Jones AV, et al. Inactivation of polycomb repressive complex 2 components in myeloproliferative and myelo-dysplastic/myeloproliferative neoplasms. Blood. 2012; 119: 1208-13
|
|
|
|
|
|
21）Nakamura S, Oshima M, Yuan J, et al. Bmi1 confers resistance to oxidative stress on hemato-poietic stem cells. PLoS One. 2012; 7: e36209
|
|
|
|
|
|
22）Kamminga LM, Bystrykh LV, de Boer A, et al. The polycomb group gene Ezh2 prevents hematopoietic stem cell exhaustion. Blood. 2006; 107: 2170-9
|
|
|
|
|
|
23）Guttman M, Donaghey J, Carey BW, et al. LincRNAs act in the circuitry controlling pluripotency and differentiation. Nature. 2011; 477: 295-300
|
|
|
|
|
|
24）Katsumoto T, Aikawa Y, Iwama A, et al. MOZ is essential for maintenance of hematopoietic stem cells. Genes Dev. 2006; 20: 1321-30
|
|
|
|
|
|
25）McMahon KA, Hiew SY, Hadjur S, et al. Mll has a critical role in fetal and adult hematopoietic stem cell self-renewal. Cell Stem Cell. 2007; 1: 338-45
|
|
|
|
|
|
26）Jude CD, Climer L, Xu D, et al. Unique and independent roles for MLL in adult hematopoietic stem cells and progenitors. Cell Stem Cell. 2007; 1: 324-37
|
|
|
|
|
|
27）Mochizuki-Kashio M, Mishima Y, Miyagi S, et al. Dependency on the polycomb gene Ezh2 distinguishes fetal from adult hematopoietic stem cells. Blood. 2011; 118: 6553-61
|
|
|
|
|
|
28）Majewski IJ, Blewitt ME, de Graaf CA, et al. Polycomb repressive complex 2(PRC2) restricts hematopoietic stem cell activity. PLoS Biol. 2008; 6: e93
|
|
|
|
|
|
29）Konuma T, Nakamura S, Miyagi S, et al. Forced expression of the histone demethylase Fbxl10 maintains self-renewing hematopoietic stem cells. Exp Hematol. 2011; 39: 697-709
|
|
|
|
|